Development Level

Tbio 5 | 10,625
Tclin 2 | 602
Tchem 1 | 1,890

IMPC Term

decreased T cell number 1 | 31
increased CD4-positive, alpha ... 1 | 15
increased leukocyte cell numbe... 1 | 37

Disease

Cancer 6 | 2,346
interstitial cystitis 6 | 2,299
Hypersensitivity reaction type II disease 4 | 235
Rheumatoid Arthritis 4 | 1,160
cutaneous lupus erythematosus 4 | 1,056
lung cancer 4 | 4,466
lung carcinoma 4 | 2,844
osteosarcoma 4 | 7,933
psoriasis 4 | 6,685
Allergic hypersensitivity disease 3 | 123
Arthritis 3 | 248
Asthma 3 | 349
Multiple Sclerosis 3 | 498
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
ovarian cancer 3 | 8,484
primary Sjogren syndrome 3 | 789
Adult T-Cell Lymphoma/Leukemia 2 | 30
Anemia 2 | 252
Breast cancer 2 | 3,094
Celiac disease 2 | 112
Dermatitis 2 | 107
Hepatitis B 2 | 103
Human immunodeficiency virus infectious disease 2 | 92
Inflammatory bowel disease 2 | 142
Influenza 2 | 142
Juvenile idiopathic arthritis 2 | 3
Kidney disease 2 | 396
Liver disease 2 | 219
Lung disease 2 | 132
Renal transplant rejection 2 | 13
Tetanus 2 | 66
Vaccinia 2 | 37
cystic fibrosis 2 | 1,665
diabetes mellitus 2 | 1,663
glioblastoma 2 | 5,572
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
invasive ductal carcinoma 2 | 2,950
malignant mesothelioma 2 | 3,162
non-small cell lung cancer 2 | 2,798
pediatric high grade glioma 2 | 2,712
primary pancreatic ductal adenocarcinoma 2 | 1,271
subependymal giant cell astrocytoma 2 | 2,287
tuberculosis 2 | 1,557
Agammaglobulinemia 1 | 24
Amenorrhea 1 | 60
Anovulation 1 | 20
Brain disease 1 | 83
COPD 1 | 113
Cardiac arrest 1 | 26
Chloracne 1 | 32
Common variable immunodeficiency 1 | 72
Diabetes Mellitus, Insulin-Dependent 1 | 76
Diabetic Cardiomyopathies 1 | 10
Diabetic Nephropathy 1 | 37
Diabetic Retinopathy 1 | 53
Diarrhea 1 | 155
Diffuse large B-cell lymphoma 1 | 41
Dumping syndrome 1 | 9
Duodenal ulcer 1 | 20
Eating disorder 1 | 24
Edema 1 | 38
Exocrine pancreatic insufficiency 1 | 21
Fatty Liver 1 | 48
Fatty liver disease 1 | 84
HIV Infections 1 | 100
Heart failure 1 | 80
Hepatitis 1 | 61
Hepatitis C 1 | 90
Histoplasmosis 1 | 22
Hyperglycemia 1 | 120
Hyperinsulinism 1 | 63
Hyperparathyroidism 1 | 43
Hyperthyroidism 1 | 50
Hypertriglyceridemia 1 | 18
Hypertrophic Cardiomyopathy 1 | 56
Hyperuricemia 1 | 35
Hypoglycemia 1 | 81
Hypogonadism 1 | 70
Hypokalemia 1 | 40
Hypopituitarism 1 | 36
Hypotension 1 | 53
Impotence 1 | 45
Juvenile rheumatoid arthritis 1 | 104
Lewy Body Disease 1 | 19
Liver Failure, Acute 1 | 22
Lupus Erythematosus, Systemic 1 | 73
Lymphoma, T-Cell, Cutaneous 1 | 21
Obstructive sleep apnea 1 | 28
Pancreatic agenesis 1 | 14
Pancreatitis 1 | 97
Panic disorder 1 | 55
Paralysed 1 | 9
Prader-Willi syndrome 1 | 45
Primary immunodeficiency disease 1 | 52
Type 1 diabetes mellitus 1 | 101
Ventricular Dysfunction, Left 1 | 15
Vitiligo 1 | 71
Weight decreased 1 | 18
Wolfram syndrome 1 | 11
maturity-onset diabetes of the young 1 | 28

Tissue

Blood and immune system 8 | 17,995
Cardiovascular System 8 | 17,958
Digestive Tract 8 | 18,473
Endocrine System 8 | 18,512
Female tissues 8 | 18,647
Liver and Pancreas 8 | 18,136
Male tissues 8 | 17,969
Nervous System 8 | 18,561
Skin and soft tissues 8 | 18,115
Urinary Tract 8 | 18,444
Respiratory system 7 | 17,484

Target Family

Non-IDG 8 | 11,971

Grant Application

1R21DK069278-01 8 | 8
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Insulin INS Tbio Non-IDG -5.14691 141255.4 1549
Inducible T-cell costimulator ICOS Tbio Non-IDG -1.41376 31.7 495
CD276 antigen CD276 Tbio Non-IDG -2.93293 733.9 392
V-set domain-containing T-cell activation inhibitor 1 VTCN1 Tbio Non-IDG -2.05577 156.3 396
T-cell-specific surface glycoprotein CD28 CD28 Tchem Non-IDG -1.85970 107.1 1174
T-lymphocyte activation antigen CD80 CD80 Tclin Non-IDG -3.35328 2343.0 1021
T-lymphocyte activation antigen CD86 CD86 Tclin Non-IDG -3.42920 2733.8 1047
Programmed cell death 1 ligand 2 PDCD1LG2 Tbio Non-IDG -2.27631 211.0 419